Impairment of MAD2B-PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas

M A Weterman1, J J van Groningen, L Tertoolen

  • 1Department of Human Genetics, University Medical Center Nijmegen, 6500 HB Nijmegen, The Netherlands. A.Geurtsvankessel@antrg.azn.nl

Insights

The PRCC-TFE3 fusion gene in papillary renal cell carcinoma (RCC) impairs the mitotic checkpoint by disrupting MAD2B interaction. This defect may be an early event in papillary RCC development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Papillary renal cell carcinoma (RCC) is associated with the (X;1)(p11;q21) translocation, fusing PRCC and TFE3 genes.
  • The molecular mechanisms driving tumorigenesis in papillary RCC remain largely unknown.

Purpose of the Study:

  • To investigate the molecular mechanism by which the PRCC-TFE3 fusion contributes to papillary RCC development.
  • To explore the role of the mitotic checkpoint in PRCC-TFE3-driven tumorigenesis.

Main Methods:

  • Co-immunoprecipitation assays to assess protein interactions.
  • Mitotic checkpoint function analysis in cancer cell lines and transfected cells.
  • Western blotting to detect protein expression and interaction.

Main Results:

  • The mitotic checkpoint protein MAD2B interacts with the wild-type PRCC protein.
  • The PRCC-TFE3 fusion protein retains the MAD2B interaction domain, but the interaction is impaired.
  • PRCC-TFE3 transfection disrupts the mitotic checkpoint in human embryonic kidney cells, suggesting a dominant-negative effect.

Conclusions:

  • The PRCC-TFE3 fusion gene likely causes papillary RCC through a dominant-negative disruption of the mitotic checkpoint.
  • Impaired MAD2B interaction and subsequent mitotic checkpoint defects are proposed as early events in papillary RCC pathogenesis.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...